LGND vs XENE

Comparison between Ligand Pharmaceuticals Inc - Class B (LGND, Company) and Xenon Pharmaceuticals Inc (XENE, Company).

Both LGND and XENE are from the Healthcare sector.

5-Year PerformanceXENE has outperformed LGND, delivering a return of +22.9% compared to +15.6%

LGND vs XENE - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	LGND(COMPANY)	XENE(COMPANY)
Market Cap	$4.97B	$4.96B
Max Drawdown	95.01%	90.43%
Sharpe Ratio	2.26	1.00
5Y Beta	0.99	0.95
Industry	Biotechnology	Biotechnology
P/E Ratio	31.77	-11.03
Forward P/E	28.65	N/A
PEG Ratio	1.53	-0.27
5Y EPS CAGR	26.59%	40.27%
Debt to Equity	0.00%	0.00%
Free Cash Flow Yield	2.47%	-6.19%
P/S Ratio	17.76	727.44
P/B Ratio	4.89	3.81

Market Cap

Winner

LGND

$4.97B

XENE

$4.96B

Max Drawdown

LGND

95.01%

Winner

XENE

90.43%

Sharpe Ratio

Winner

LGND

2.26

XENE

1.00

5Y Beta

LGND

0.99

Winner

XENE

0.95

Industry

LGND

Biotechnology

XENE

Biotechnology

P/E Ratio

LGND

31.77

Winner

XENE

-11.03

Forward P/E

LGND

28.65

XENE

N/A

PEG Ratio

LGND

1.53

Winner

XENE

-0.27

5Y EPS CAGR

LGND

26.59%

Winner

XENE

40.27%

Debt to Equity

LGND

0.00%

XENE

0.00%

Free Cash Flow Yield

Winner

LGND

2.47%

XENE

-6.19%

P/S Ratio

Winner

LGND

17.76

XENE

727.44

P/B Ratio

LGND

4.89

Winner

XENE

3.81

LGND vs XENE - Historical Returns

Returns include dividend reinvestment.

Period	LGND	XENE
1 month	+15.11%	-5.27%
3 months	+20.83%	-10.02%
6 months	+34.81%	+18.25%
1 year	+123.28%	+58.84%
5 years(CAGR)	+15.62%	+22.87%
10 years(CAGR)	+8.50%	+21.88%
Max(CAGR)	+15.14%	+14.81%

Winner

LGND

+15.11%

XENE

-5.27%

Winner

LGND

+20.83%

XENE

-10.02%

Winner

LGND

+34.81%

XENE

+18.25%

Winner

LGND

+123.28%

XENE

+58.84%

5Y(CAGR)

LGND

+15.62%

Winner

XENE

+22.87%

10Y(CAGR)

LGND

+8.50%

Winner

XENE

+21.88%

Max(CAGR)

Winner

LGND

+15.14%

XENE

+14.81%

LGND vs XENE - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	LGND	XENE
2026	+34.42%	+17.10%
2025	+74.39%	+11.58%
2024	+48.18%	-12.71%
2023	+8.16%	+23.62%
2022	-55.93%	+24.82%
2021	+52.82%	+111.94%
2020	-5.05%	+12.10%
2019	-23.88%	+96.26%
2018	-2.11%	+119.48%
2017	+33.59%	-64.01%
2016	-0.84%	-3.27%
2015	+101.79%	-57.01%
2014	+3.28%	+88.10%
2013	+153.86%	N/A
2012	+74.14%	N/A
2011	+32.04%	N/A
2010	+334.22%	N/A
2009	-19.63%	N/A
2008	-43.62%	N/A
2007	-41.09%	N/A
2006	-4.78%	N/A
2005	-0.45%	N/A
2004	-22.04%	N/A
2003	+168.56%	N/A
2002	-68.50%	N/A
2001	+30.18%	N/A
2000	+0.86%	N/A
1999	+52.61%	N/A

LGND vs XENE Drawdown Comparison

The maximum drawdown for LGND was -93.36%, occurring on Nov 19, 2008. Recovery took 3033 trading sessions.

The maximum drawdown for XENE was -90.43%, occurring on Nov 14, 2017. Recovery took 1696 trading sessions.

The current LGND drawdown is -6.90%. The current XENE drawdown is -16.99%.

Rank	LGND	XENE
#1	-93.36% Mar 6, 2000 - Mar 26, 2012	-90.43% Jan 8, 2015 - Oct 4, 2021
#2	-81.94% Sep 28, 2018 - Oct 27, 2023	-43.59% Feb 9, 2024 - Mar 9, 2026
#3	-46.77% Mar 18, 2014 - Apr 8, 2015	-34.08% May 9, 2023 - Dec 22, 2023
#4	-37.01% Mar 26, 2012 - Jul 26, 2012	-30.14% Nov 5, 2021 - Aug 4, 2022
#5	-34.19% Aug 1, 2016 - Oct 4, 2017	-25.87% Nov 11, 2014 - Dec 11, 2014
#6	-26.20% Aug 5, 2015 - Dec 16, 2015	-18.40% Mar 9, 2026 - Jun 8, 2026
#7	-23.30% Dec 17, 2015 - Apr 6, 2016	-17.08% Mar 1, 2023 - May 3, 2023
#8	-21.24% Oct 29, 2013 - Jan 10, 2014	-16.98% Aug 24, 2022 - Feb 13, 2023
#9	-21.19% Jul 31, 2012 - Nov 26, 2012	-11.44% Oct 15, 2021 - Nov 2, 2021
#10	-17.44% Mar 12, 2018 - May 15, 2018	-11.09% Dec 11, 2014 - Dec 29, 2014
#11	-17.40% Jul 22, 2013 - Oct 17, 2013	-9.36% Feb 13, 2023 - Mar 1, 2023
#12	-16.85% Dec 10, 1999 - Dec 29, 1999	-8.58% Jan 8, 2024 - Feb 8, 2024
#13	-16.72% Jan 24, 2000 - Feb 10, 2000	-8.27% Aug 10, 2022 - Aug 24, 2022
#14	-14.25% Apr 21, 2016 - Jul 20, 2016	-6.08% Dec 29, 2014 - Jan 7, 2015
#15	-14.12% Feb 18, 2000 - Mar 6, 2000	-4.89% Dec 27, 2023 - Jan 8, 2024